Tdap, MenACWY Coverage Increased in Teens From 2023 to 2024

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

TUESDAY, Aug. 19, 2025 -- From 2023 to 2024, coverage with one or more doses of the tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) and the quadrivalent meningococcal conjugate vaccine (MenACWY) increased, while human papillomavirus (HPV) vaccination coverage remained stable, according to research published in the Aug. 14 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Cassandra Pingali, M.P.H., from the CDC in Atlanta, and colleagues analyzed data from the 2024 National Immunization Survey-Teen to examine national, state, and selected local area vaccination coverage in 2024. Data were included for 16,325 adolescents aged 13 to 17 years.

The researchers found that coverage with one or more Tdap dose increased from 89.0 to 91.3 percent from 2023 to 2024; coverage with one or more MenACWY doses increased from 88.4 to 90.1 percent. For the third consecutive year, HPV vaccination coverage remained stable, with 78.2 and 62.9 percent of adolescents having received one or more doses and being up to date with the HPV vaccination series, respectively. Coverage with one or more Tdap doses and one or more MenACWY doses was ≥90 percent in 39 and 30 states, respectively, while coverage with one or more dose of the HPV vaccine was ≥80 percent in 26 states and the District of Columbia. Lower HPV vaccination coverage in nonmetropolitan statistical areas (MSAs) persisted compared with that seen in MSA principal cities.

"Health departments can work with health care providers and communities to improve local vaccine access and increase adolescent vaccination coverage," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-08-20 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords